ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

ClinicalTrials.gov ID: NCT01360021

Public ClinicalTrials.gov record NCT01360021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Double-blind, Randomized, Multi-centre, Parallel-group Study Evaluating the Efficacy Safety, and Patient Use (User Study) of Symbicort® (Budesonide/Formoterol) Breath Actuated Metered Dose Inhaler (BA MDI) 2x160/4.5 μg Twice Daily Compared With Symbicort (Budesonide/Formoterol) AC (Actuation Counter) pMDI® 2x160/4.5 μg Twice Daily and Budesonide AC pMDI 2x160 μg Twice Daily in Adult and Adolescent Asthmatics

Study identification

NCT ID
NCT01360021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
214 participants

Conditions and interventions

Conditions

Interventions

  • Budesonide Drug
  • Symbicort Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Jul 31, 2012
Completion
Jul 31, 2012
Last update posted
Mar 10, 2014

2011 – 2012

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Research Site Huntington Beach California
Research Site Long Beach California
Research Site Los Angeles California
Research Site Orange California
Research Site Rancho Mirage California
Research Site Riverside California
Research Site Sacramento California
Research Site San Diego California
Research Site San Jose California
Research Site Tallahassee Florida
Research Site Savannah Georgia
Research Site River Forest Illinois
Research Site Louisville Kentucky
Research Site Metairie Louisiana
Research Site Bangor Maine
Research Site Wheaton Maryland
Research Site North Dartmouth Massachusetts
Research Site Columbia Missouri
Research Site Rolla Missouri
Research Site Skillman New Jersey
Research Site North Syracuse New York
Research Site Rochester New York
Research Site Cincinnati Ohio
Research Site Collegeville Pennsylvania
Research Site Lincoln Rhode Island
Research Site Charleston South Carolina
Research Site Spartanburg South Carolina
Research Site Dallas Texas
Research Site Tacoma Washington
Research Site Greenfield Wisconsin
Research Site Madison Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01360021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2014 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01360021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →